Hasil Pencarian - Li‐Na He
- Menampilkan 1 - 11 hasil dari 11
-
1
Predictive strategies for oocyte maturation in IVF cycles: from single indicators to integrated models oleh Li-Na He, Qing Xu, Jie Lin, Yi Liu, Wei Chen
Diterbitkan 2024-06-01
Artikel -
2
LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy oleh Linfeng Luo, Linfeng Luo, Linfeng Luo, Sha Fu, Sha Fu, Wei Du, Wei Du, Wei Du, Li-na He, Li-na He, Li-na He, Xuanye Zhang, Xuanye Zhang, Xuanye Zhang, Yixing Wang, Yixing Wang, Yixing Wang, Yixin Zhou, Yixin Zhou, Yixin Zhou, Shaodong Hong, Shaodong Hong, Shaodong Hong
Diterbitkan 2023-01-01
Artikel -
3
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma oleh Xuanye Zhang, Xuanye Zhang, Xuanye Zhang, Yixin Zhou, Yixin Zhou, Yixin Zhou, Hualin Chen, Chen Chen, Chen Chen, Chen Chen, Zuan Lin, Zuan Lin, Zuan Lin, Li-na He, Li-na He, Li-na He, Wei Du, Wei Du, Wei Du, Tao Chen, Tao Chen, Tao Chen, Shaodong Hong, Shaodong Hong, Shaodong Hong, Sha Fu, Sha Fu
Diterbitkan 2022-09-01
Artikel -
4
AStruct: detection of allele-specific RNA secondary structure in structuromic probing data oleh Qingru Xu, Xiaoqiong Bao, Zhuobin Lin, Lin Tang, Li-na He, Jian Ren, Zhixiang Zuo, Kunhua Hu
Diterbitkan 2024-03-01
Artikel -
5
tigeR: Tumor immunotherapy gene expression data analysis R package oleh Yihao Chen, Li‐Na He, Yuanzhe Zhang, Jingru Gong, Shuangbin Xu, Yuelong Shu, Di Zhang, Guangchuang Yu, Zhixiang Zuo
Diterbitkan 2024-10-01
Artikel -
6
Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer oleh Chen Chen, Chen Chen, Yixin Zhou, Yixin Zhou, Xuanye Zhang, Xuanye Zhang, Yuhong Wang, Yuhong Wang, Li-na He, Li-na He, Zuan Lin, Zuan Lin, Tao Chen, Tao Chen, Yongluo Jiang, Yongluo Jiang, Shaodong Hong, Shaodong Hong, Li Zhang, Li Zhang
Diterbitkan 2021-10-01
Artikel -
7
Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy oleh Li-na He, Li-na He, Li-na He, Xuanye Zhang, Xuanye Zhang, Xuanye Zhang, Haifeng Li, Haifeng Li, Haifeng Li, Tao Chen, Tao Chen, Tao Chen, Chen Chen, Chen Chen, Chen Chen, Yixin Zhou, Yixin Zhou, Yixin Zhou, Zuan Lin, Zuan Lin, Zuan Lin, Wei Du, Wei Du, Wei Du, Wenfeng Fang, Wenfeng Fang, Wenfeng Fang, Yunpeng Yang, Yunpeng Yang, Yunpeng Yang, Yan Huang, Yan Huang, Yan Huang, Hongyun Zhao, Hongyun Zhao, Hongyun Zhao, Shaodong Hong, Shaodong Hong, Shaodong Hong, Li Zhang, Li Zhang, Li Zhang
Diterbitkan 2021-01-01
Artikel -
8
Retraction Note: MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2 oleh Wen-Fei Wei, Chen-Fei Zhou, Xiang-Guang Wu, Li-Na He, Lan-Fang Wu, Xiao-Jing Chen, Rui-Ming Yan, Mei Zhong, Yan-Hong Yu, Li Liang, Wei Wang
Diterbitkan 2022-12-01
Artikel -
9
A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment oleh Yongluo Jiang, Yixing Wang, Sha Fu, Tao Chen, Yixin Zhou, Xuanye Zhang, Chen Chen, Li‐na He, Wei Du, Haifeng Li, Zuan Lin, Yuanyuan Zhao, Yunpeng Yang, Hongyun Zhao, Wenfeng Fang, Yan Huang, Shaodong Hong, Li Zhang
Diterbitkan 2022-06-01
Artikel -
10
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor oleh Li-Na He, Tao Chen, Sha Fu, Yongluo Jiang, Xuanye Zhang, Chen Chen, Wei Du, Linfeng Luo, Anlin Li, Yixing Wang, Hui Yu, Yixin Zhou, Yuhong Wang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Wenfeng Fang, Li Zhang, Shaodong Hong
Diterbitkan 2023-10-01
Artikel -
11
Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy oleh Li-Na He, Haifeng Li, Wei Du, Sha Fu, Linfeng luo, Tao Chen, Xuanye Zhang, Chen Chen, Yongluo Jiang, Yixing Wang, Yuhong Wang, Hui Yu, Yixin Zhou, Zuan Lin, Yuanyuan Zhao, Yan Huang, Hongyun Zhao, Wenfeng Fang, Yunpeng Yang, Li Zhang, Shaodong Hong
Diterbitkan 2023-07-01
Artikel